Free Tool

Weight loss calculator

See your projected weight loss with Tirzepatide based on published clinical trial data.

Current weight (kg)

Height (cm)

Treatment duration: 6 months

3 months12 months

—

projected weight loss

—

Starting weight

—

Projected weight

—

Projected BMI

Start your assessment →

Based on average outcomes from the SURMOUNT-1 clinical trial (tirzepatide 15mg, 72 weeks). Individual results vary. This is an estimate, not a guarantee or personal medical advice.

Based on clinical trial evidence

22.5%

Average body weight reduction with tirzepatide 15mg over 72 weeks in the SURMOUNT-1 trial.

Jastreboff et al., NEJM 2022; 387:205-216

96%

Of participants on tirzepatide 15mg achieved ≥5% weight loss in SURMOUNT-1.

Jastreboff et al., NEJM 2022; 387:205-216

63%

Of participants on tirzepatide 15mg achieved ≥20% weight loss in SURMOUNT-1.

Jastreboff et al., NEJM 2022; 387:205-216

2.5mg

The usual starting dose, used to help your body adjust before any higher-dose step-up.

Second Cure dosing path